Positive Q2 results from Duos Technologies contribute to a rise in stock prices alongside Amylyx Pharmaceuticals, Weave Communications, and other major companies on Tuesday.

Aug 18, 2026, 10:20 AM ETResultsRead the original at benzinga.com

Neutral

Duos Technologies reported Q2 earnings of $1.37 per share, beating estimates, and sales of $6.175 million, also exceeding expectations.

DUOT · Duos Technologies Group Inc

AI read · Neutral

The AI's read

DUOT reported Q2 EPS $1.37 vs $0.66 est and revenue $6.175M vs $4.9M, and shares popped about 21%. That’s real upside on the numbers and why the stock jumped hard today. Price action looks largely priced in already. RSI 74 and a ~20% intraday run leave momentum stretched and limited immediate upside. Our take is neutral. We’d want clear follow-through or a pullback before leaning bullish because the market already moved the needle.

AMLX · Amylyx Pharmaceuticals Inc

AI read · Good for AMLX

The connection

Amylyx Pharmaceuticals shares surged after announcing positive results from its Phase 3 trial.

WEAV · Weave Communications Inc

AI read · Good for WEAV

The connection

Weave Communications shares rose sharply following the announcement of its acquisition by Francisco Partners.

Get alerts for DUOT

Follow Duos Technologies Group Inc (DUOT) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for DUOT

Free on the App Store and Google Play, or on the web.